Joshua K Tay completed his undergraduate medical training at the National University of Singapore in 2007, achieving a distinction in the Undergraduate Research Opportunities Programme and winning the Outstanding Undergraduate Researcher Prize. He underwent specialty training in Otolaryngology–Head & Neck Surgery in Singapore and was awarded the College of Surgeons Gold Medal for the best-performing resident at the Otolaryngology Exit Examinations in 2015. He was awarded the Ministry of Health Healthcare Research Scholarship, during which he completed a PhD in Cancer Biology at the Stanford University School of Medicine, focusing on molecular subtypes of nasopharyngeal cancer, under the guidance of Professors John B. Sunwoo and Robert B. West. His research involves classifying tumors based on their gene signatures and matching them with targeted therapies for personalized treatment. Together with A/Prof Thomas Loh, he leads a Head and Neck Cancer Genomics laboratory at NUS, with special expertise in microdissected gene expression profiling from paraffin specimens. During the COVID-19 pandemic, he led multi-center clinical diagnostic studies to validate 3D-printed and injection-molded nasopharyngeal swab prototypes for SARS-CoV-2 testing. He also works closely with biomedical engineers and researchers to improve the outcomes of diagnostic tests and cancer screening. He is currently a Consultant in the Department of Otolaryngology.
Joshua K Tay completed his undergraduate medical training at the National University of Singapore in 2007, achieving a distinction in the Undergraduate Research Opportunities Programme and winning the Outstanding Undergraduate Researcher Prize. He underwent specialty training in Otolaryngology–Head & Neck Surgery in Singapore and was awarded the College of Surgeons Gold Medal for the best-performing resident at the Otolaryngology Exit Examinations in 2015. He was awarded the Ministry of Health Healthcare Research Scholarship, during which he completed a PhD in Cancer Biology at the Stanford University School of Medicine, focusing on molecular subtypes of nasopharyngeal cancer, under the guidance of Professors John B. Sunwoo and Robert B. West. His research involves classifying tumors based on their gene signatures and matching them with targeted therapies for personalized treatment. Together with A/Prof Thomas Loh, he leads a Head and Neck Cancer Genomics laboratory at NUS, with special expertise in microdissected gene expression profiling from paraffin specimens. During the COVID-19 pandemic, he led multi-center clinical diagnostic studies to validate 3D-printed and injection-molded nasopharyngeal swab prototypes for SARS-CoV-2 testing. He also works closely with biomedical engineers and researchers to improve the outcomes of diagnostic tests and cancer screening. He is currently a Consultant in the Department of Otolaryngology.